EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Automated Multienzyme Digestion Workflows for Confident Characterization of Challenging Posttranslational Modifications in Therapeutic Antibodies by LC–MS/MS

Nanna Sofie Eskesen, Yann Leblanc, Justine Lempereur, Martin Ørgaard, Elizabeta Madzharova, Trine M Sloth, Simon Krabbe, Alexandra K Rebak, Magali André, Pernille F Jensen, Dan B Kristensen iD

Rapid Communications in Mass Spectrometry · 15.11.2026 · 40 (21)

DOI: 10.1002/rcm.70165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, online erschienen am 24.08.2026. Verfasst von Nanna Sofie Eskesen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Servier Symphogen, Ballerup, Denmark. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry, Protein Processing, Post-Translational, Immunoconjugates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Non‐reduced trypsin digestion of therapeutic antibodies can generate large disulfide‐linked peptide complexes that exhibit poor chromatographic and mass spectrometric performance. This limits the confident characterization of posttranslational modifications (PTMs) in specific antibody regions, such as the heavy‐chain constant region 1 (CH1) domain, where conventional digestion produces 8‐kDa complexes with poor fragmentation.

Methods

We developed automated multistep and multienzyme digestion workflows using immobilized trypsin, chymotrypsin, and proteinase K on magnetic beads. These workflows were implemented on a robotic platform and evaluated for their ability to characterize engineered cysteine residues in the CH1 domain of antibody–drug conjugate (ADC) intermediates. Analysis was performed using liquid chromatography–tandem mass spectrometry (LC–MS/MS).

Results

The multienzyme workflows generated highly orthogonal peptide pools; for instance, selected workflows using trypsin only, trypsin combined with chymotrypsin, and trypsin combined with proteinase K yielded 13%, 14%, and 34% unique peptide identifications, respectively. In the challenging CH1 region, the multienzyme approach identified six distinct cysteine adducts at engineered Cys152. These included cysteinylation, homocysteinylation, and an unexpected, putative process‐related impurity, thioglycolic acid capping, which was validated with unambiguous MS and MS/MS evidence using selected multienzyme workflows. Relative extracted‐ion current‐based levels of these cappings were observed and found to be similar across selected workflows; for instance, relative levels of thioglycolic acid capping from 12% to 15% were observed across selected workflows.

Conclusions

The presented automated multienzyme workflows serve as complementary tools in an analytical toolbox, which can be strategically deployed for targeting challenging regions of biopharmaceutical products. We demonstrate significantly improved precursor signal quality and MS/MS sequence coverage compared to trypsin‐only protocols. The presented workflows are fast (36–92 min total runtime) and utilize commercially available reagents and instrumentation, making them suitable for direct implementation in biopharmaceutical analytical development and quality control laboratories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryLiquid Chromatography-Mass SpectrometryProtein Processing, Post-TranslationalImmunoconjugatesAntibodiesTrypsinChymotrypsinEndopeptidase KAmino Acid SequenceAutomationEnzymes, ImmobilizedHumansCysteine

Stichwörter der Autor:innen

LC–MS/MSantibody–drug conjugateautomationcysteine cappingmultienzyme digestionmulti‐attribute methodpeptide mappingproteinase K

Substanzen

TrypsinChymotrypsinEndopeptidase KImmunoconjugatesEnzymes, ImmobilizedCysteineAntibodies

Autor:innen und Institutionen

  • Servier Symphogen, Ballerup, Denmark.
  • Structural Biophysics and Protein Sciences, Servier R&D Center, Gif-sur-Yvette, France.

ORCID-Profile: Dan B Kristensen

Zitieren

APA

Eskesen, N. S., Leblanc, Y., Lempereur, J., Ørgaard, M., Madzharova, E., Sloth, T. M., Krabbe, S., Rebak, A. K., André, M., Jensen, P. F., & Kristensen, D. B. (2026). Automated Multienzyme Digestion Workflows for Confident Characterization of Challenging Posttranslational Modifications in Therapeutic Antibodies by LC–MS/MS. Rapid Communications in Mass Spectrometry, 40(21). https://doi.org/10.1002/rcm.70165

Vancouver

Eskesen NS, Leblanc Y, Lempereur J, Ørgaard M, Madzharova E, Sloth TM, et al. Automated Multienzyme Digestion Workflows for Confident Characterization of Challenging Posttranslational Modifications in Therapeutic Antibodies by LC–MS/MS. Rapid Communications in Mass Spectrometry. 2026;40(21). doi:10.1002/rcm.70165

BibTeX
@article{Eskesen2026,
  author = {Eskesen, Nanna Sofie and Leblanc, Yann and Lempereur, Justine and Ørgaard, Martin and Madzharova, Elizabeta and Sloth, Trine M and Krabbe, Simon and Rebak, Alexandra K and André, Magali and Jensen, Pernille F and Kristensen, Dan B},
  title = {Automated Multienzyme Digestion Workflows for Confident Characterization of Challenging Posttranslational Modifications in Therapeutic Antibodies by LC–MS/MS},
  journal = {Rapid Communications in Mass Spectrometry},
  year = {2026},
  volume = {40},
  number = {21},
  doi = {10.1002/rcm.70165}
}
Kostenlos starten →